Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-54,033
Closed -$252K 4953
2026
Q1
$252K Buy
+54,033
New +$302K ﹤0.01% 3030
2025
Q2
Sell
-184,889
Closed -$1.31M 3236
2025
Q1
$1.31M Buy
184,889
+68,933
+59% +$613K 0.01% 1004
2024
Q4
$1.08M Buy
115,956
+70,587
+156% +$791K 0.01% 1038
2024
Q3
$592K Sell
45,369
-27,610
-38% -$369K ﹤0.01% 1511
2024
Q2
$1.11M Buy
72,979
+49,576
+212% +$652K 0.01% 974
2024
Q1
$305K Buy
23,403
+11,531
+97% +$153K ﹤0.01% 1538
2023
Q4
$157K Buy
+11,872
New +$151K ﹤0.01% 1832
2022
Q2
Sell
-352,575
Closed -$3.21M 3433
2022
Q1
$3.21M Buy
+352,575
New +$3.72M 0.02% 433

Other funds holding NABL

HRT Financial's NABL Position: Q2 2026 in Review

HRT Financial sold out of N-able (NABL) in Q2 2026, closing a stake of 54,033 shares — an estimated $252K sold.

HRT Financial first reported a position in NABL in Q1 2022 and held it in 8 quarters. The position peaked at $3.21M in Q1 2022. 200 funds tracked by Wall St. Rank hold NABL as of Q2 2026.

  • HRT Financial reported no remaining N-able position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 54,033 N-able shares in Q2 2026, an estimated $252K.
  • HRT Financial first reported a position in N-able in Q1 2022 and held it in 8 quarters.
  • HRT Financial's N-able position peaked at $3.21M in Q1 2022.
  • 200 funds tracked by Wall St. Rank held N-able as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.